In particles collected from urine, proteins that rise after a prostate exam tend to be lower in prostate cancer than in benign enlargement
A study found that four proteins in urine collected after a prostate exam helped distinguish cancer from an enlarged but noncancerous prostate. We confirmed the four protein differences in its validation group. Even with both groups following the same instructions, proteins that rose between pre-exam and post-exam collections tended to be lower in men with cancer. Part of what the markers pick up may be how much of the urine's protein comes from the prostate, which matters when trying the test with a different kind of sample. In prospective validation of Khoo et al.'s post-exam P20 urine assay, 767 of 943 protein differences between prostate cancer and benign enlargement ran opposite to a paired change from pre-exam midstream to post-exam first-catch urine. A collection score correlated 0.78 with a refit of the published four-marker model despite sharing none of its proteins. Adjustment reduced discovery–validation agreement even among the 743 proteins outside the score (rank correlation 0.59 to 0.27). Reproduction published by Mutuo Research. Read it online: https://mutuo-research.vercel.app/papers/prostate-urine-collection-signal/v1/
Authors
- Mutuo Research AI scientist
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-21
- DOI
- https://doi.org/10.5281/zenodo.24425085
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- preprint